Publications

5803 Results

Centralized blood processing for the Selenium and Vitamin E Cancer Prevention Trial: Effects of delayed processing on carotenoids, tocopherols, insulin-like growth factor-I, insulin-like growth factor binding protein 3, steroid hormones and lymphocyte viability

Authors
AR Kristal;IB King;D Albanes;MN Pollak;FZ Stanzyk;RM Santella;A Hoque
Journal / Conference
Cancer Biomarkers & Prevention 14(3):727-730
Year
2005
Research Committee(s)
Prevention, Screening, and and Surveillance
Study Number(s)
S0000

SWOG 0127: phase II trial of erlotinib in GEJ and gastric adenocarcinomas

Authors
T Dragovich;S McCoy;SG Urba;KS Zaner;CM Fenoglio-Preiser;CD Blanke;JL Abbruzzese
Journal / Conference
ASCO 2005 Gastrointestinal Cancers Symposium #49
Year
2005
Research Committee(s)
Gastrointestinal
Study Number(s)
S0127

Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG Trial SWOG 9706

Authors
MA Hussein;H Gundacker;DR Head;L Elias;KA Foon;DH Boldt;S Dobin;SR Dakhil;GT Budd;FR Appelbaum
Journal / Conference
Leukemia 19:1880-1886
Year
2005
Research Committee(s)
Leukemia
Study Number(s)
S9706

Adjuvant radiotherapy for pathologic T3 prostate cancer: results of a randomized, prospective clinical trial with metastasis-free survival endpoint

Authors
IM Thompson;C Tangen;G Miller;MS Lucia;D Troyer;J Paradelo;J Chin;E Messing;E Canby-Hagino;J Forman;ED Crawford
Journal / Conference
Journal of Urology 173(4):451 (#1665)
Year
2005
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8794

Pathological assessment of high grade tumors in the Prostate Cancer Prevention Trial (PCPT)

Authors
MS Lucia;A Darke;P Goodman;C Tangen;CA Coltman;IM Thompson
Journal / Conference
Journal of Urology 173(4):451 (#1664)
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Prostate specific antigen (PSA) as a predictor of adverse pathological features at prostatectomy in the Prostate Cancer Prevention Trial (PCPT)

Authors
MS Lucia;P Goodman;C Tangen;CA Coltman;IM Thompson
Journal / Conference
Journal of Urology 173(4):143 (#525)
Year
2005
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Short-and long-term genitourinary symptom status and global quality of life (QOL) from a Southwest Oncology Group (SWOG) trial

Authors
KA Hayden;CM Moinpour;J Faulkner;CM Tangen;ED Canby-Hagino;D Lemmon;S Breslin;IM Thompson;ED Crawford
Journal / Conference
Proc of the ASCO, JCO 23(16S):391s (#4556)
Year
2005
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8994 (EST-C-0690) (INT-0086)

Prognostic value of cell cycle regulators p27 and cyclin E: tissue microarray analysis of 1753 women enrolled in SWOG breast cancer trial 9313

Authors
PL Porter;W Barlow;IT Yeh;MG Lin;X Yuan;JN Ingle;CL Shapiro;GP Sledge;RB Livingston;DF Hayes
Journal / Conference
Proc of the ASCO, JCO 23(16S):5s (#507)
Year
2005
Research Committee(s)
Breast
Study Number(s)
SWOG-9313

Relationship between pretreatment CA-125 level and risk of relapse in advanced ovarian cancer (AOC) patients in a complete clinical response (CCR) who received "maintenance therapy"

Authors
PY Liu;DS Alberts;BJ Monk;M Brady;M Markman
Journal / Conference
Proc of the ASO, JCO 23(16S):458s (#5013)
Year
2005
Research Committee(s)
Gynecologic
Study Number(s)
S9701

Long term survival in stage IIIb non-small cell lung cancer (NSCLC) treated with consolidation docetaxel following concurrent chemoradiotherapy (SWOG S9504)

Authors
DR Gandara;K Chansky;LE Gaspar;KS Albain;PN Lara;J Crowley
Journal / Conference
Proc of the ASCO, JCO 23(16S):635s (#7059)
Year
2005
Research Committee(s)
Lung
Study Number(s)
SWOG-9504